Eszopiclone and Olopatadine hydrochloride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Eszopiclone (eszopiclone) and Olopatadine hydrochloride (olopatadine hydrochloride). Common drug interactions include pneumoperitoneum among females and adrenal insufficiency among males.

The phase IV clinical study analyzes what interactions people have when they take Eszopiclone and Olopatadine hydrochloride. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Eszopiclone?

Eszopiclone has active ingredients of eszopiclone. It is often used in insomnia. eHealthMe is studying from 4,258 Eszopiclone users. Check the latest studies of Eszopiclone.

What is Olopatadine hydrochloride?

Olopatadine hydrochloride has active ingredients of olopatadine hydrochloride. eHealthMe is studying from 4,420 Olopatadine hydrochloride users. Check the latest studies of Olopatadine hydrochloride.

On Jul, 31, 2026

18 people who take Eszopiclone and Olopatadine hydrochloride together, and have interactions are studied.

Eszopiclone and Olopatadine hydrochloride drug interactions.

What are the common drug interactions of Eszopiclone and Olopatadine Hydrochloride, by gender? *:

female:

Pneumoperitoneum (air or gas in the abdominal (peritoneal) cavity)
Back pain
Headache (pain in head)
Hypertension (high blood pressure)
Infusion related reaction
Nausea (feeling of having an urge to vomit)
Sinusitis (inflammation of sinus)
Upper respiratory tract infection
Interstitial lung disease

male:

Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
Febrile neutropenia (fever with reduced white blood cells)
Hypokalaemia (low potassium)
Interstitial lung disease
Liver disorder (liver diseases)
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Oedema peripheral (superficial swelling)
Platelet count decreased
Pyrexia (fever)
Septic shock (shock due to blood infection)

What are the common drug interactions of Eszopiclone and Olopatadine Hydrochloride, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Pneumonitis (inflammation of the walls of the alveoli in the lungs)

40-49:

Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
Interstitial lung disease

50-59:

Sepsis (a severe blood infection that can lead to organ failure and death)
Septic shock (shock due to blood infection)

60+:

Pneumoperitoneum (air or gas in the abdominal (peritoneal) cavity)
Back pain
Renal disorder (kidney disease)
Anaemia (lack of blood)
Drug hypersensitivity
Electrocardiogram qt prolonged
Face oedema (swelling of face)
Hypokalaemia (low potassium)
Interstitial lung disease
Liver disorder (liver diseases)

What are the existing conditions these people have? *

Constipation: 9 people, 50.00%
Diarrhea: 6 people, 33.33%
Nausea (feeling of having an urge to vomit): 6 people, 33.33%
Rashes (redness): 6 people, 33.33%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 5 people, 27.78%
Pneumonia: 4 people, 22.22%
Lung Cancer - Non-Small Cell (lung cancer): 4 people, 22.22%
Rash Maculo-Papular (red area on the skin that is covered with small confluent bumps): 4 people, 22.22%
Gastric Ulcer (stomach ulcer): 4 people, 22.22%
High Blood Pressure: 4 people, 22.22%

* Approximation only. Some reports may have incomplete information.

Do you take Eszopiclone and Olopatadine hydrochloride?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously